Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

4yrs ago Hedge Fund hedgeweek Views: 222

30th Jan 2020 - 9:54am

Kempen launches renewable energy equities research team

Submitted 30/01/2020 - 9:54am

Kempen & Co (Kempen) has launched a new range of research reports on companies and funds operating in the renewable energy sector.

The research team comprises Kempen’s equity analysts Charles Maynadier, Juri Zanieri and Stuart Gillies; a team with many years’ experience in the infrastructure sector. Kempen can thus now offer institutional investors access to dedicated, high-quality equity research on companies and funds in the renewable energy sector.

 
The first four companies to be analysed are: Greencoat UK Wind, Greencoat Renewables, NextEnergy Solar and Bluefield Solar.
 
Charles Maynadier, equity analyst at Kempen & Co, explains: “At Kempen, we believe the global energy sector is currently facing two major challenges: on the one hand, there’s the need to meet the growing demand for energy and, on the other, the need to reduce CO2 emissions.
 
“As we see it, we stand on the forefront of an energy transition to low-carbon energy sources and further electrification of society. We are witnessing a sharp upturn in demand for equity research into funds that offer technological solutions in this transition.
 
“This step fits within both Kempen’s strategy of specialisation and focus on specific industries and the significant growth it forecasts for the renewable energy market.”
 
Elbert Rodenburg, Managing Director Securities at Kempen & Co: “We are very keen to set to work on equity research in the renewable energy sector. This step allows us to respond to the ongoing professionalisation of the relatively young market for renewable energy. We have put together a highly-skilled, experienced team that unites a large amount of market knowledge and expertise for making this niche line of research a success.”
 
Kempen & Co Securities focuses on securities brokerage, mainly in European real estate companies, Local Alpha equities, Life Sciences & Healthcare companies, FIG and FinTech and Infrastructure, on behalf of institutional investors in Europe and the US. Kempen & Co Securities offers its clients high-quality research and order execution.

Tags Compliance Research & Analytics

Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.